---
title: "Johnson & Johnson (JNJ) Gets a Buy from Citi"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294930317.md"
description: "Citi analyst Joanne Wuensch maintained a Buy rating on Johnson & Johnson (JNJ), whose shares closed at $254.93. This follows a similar Buy recommendation from Scotiabank's Louise Chen. Conversely, Bank of America Securities reiterated a Hold rating on the stock on July 28."
datetime: "2026-08-05T08:05:23.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294930317.md)
  - [en](https://longbridge.com/en/news/294930317.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294930317.md)
generator: "portal-rs"
---

# Johnson & Johnson (JNJ) Gets a Buy from Citi

Citi analyst Joanne Wuensch maintained a Buy rating on Johnson & Johnson yesterday. The company’s shares closed yesterday at $254.93.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

Wuensch covers the Healthcare sector, focusing on stocks such as Abbott Laboratories, Integra Lifesciences, and Baxter International. According to TipRanks, Wuensch has an average return of 1.8% and a 53.74% success rate on recommended stocks. 

In addition to Citi, Johnson & Johnson also received a Buy from Scotiabank’s Louise Chen in a report issued yesterday. However, on July 28, Bank of America Securities reiterated a Hold rating on Johnson & Johnson (NYSE: JNJ).

### Related Stocks

- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [C.US](https://longbridge.com/en/quote/C.US.md)
- [ABT.US](https://longbridge.com/en/quote/ABT.US.md)
- [IART.US](https://longbridge.com/en/quote/IART.US.md)
- [BAX.US](https://longbridge.com/en/quote/BAX.US.md)
- [BNS.US](https://longbridge.com/en/quote/BNS.US.md)
- [BAC.US](https://longbridge.com/en/quote/BAC.US.md)
- [C-R.US](https://longbridge.com/en/quote/C-R.US.md)
- [BAC-Q.US](https://longbridge.com/en/quote/BAC-Q.US.md)
- [BML-L.US](https://longbridge.com/en/quote/BML-L.US.md)
- [BAC-L.US](https://longbridge.com/en/quote/BAC-L.US.md)
- [BAC-K.US](https://longbridge.com/en/quote/BAC-K.US.md)
- [BML-H.US](https://longbridge.com/en/quote/BML-H.US.md)
- [BAC-N.US](https://longbridge.com/en/quote/BAC-N.US.md)
- [BAC-E.US](https://longbridge.com/en/quote/BAC-E.US.md)
- [MER-K.US](https://longbridge.com/en/quote/MER-K.US.md)
- [BAC-O.US](https://longbridge.com/en/quote/BAC-O.US.md)
- [BML-G.US](https://longbridge.com/en/quote/BML-G.US.md)
- [BAC-M.US](https://longbridge.com/en/quote/BAC-M.US.md)
- [BAC-B.US](https://longbridge.com/en/quote/BAC-B.US.md)
- [BML-J.US](https://longbridge.com/en/quote/BML-J.US.md)
- [BAC-S.US](https://longbridge.com/en/quote/BAC-S.US.md)
- [BAC-P.US](https://longbridge.com/en/quote/BAC-P.US.md)
- [8648.JP](https://longbridge.com/en/quote/8648.JP.md)

## Related News & Research

- [Trinity Legacy Partners LLC Sells 4,917 Shares of Johnson & Johnson $JNJ](https://longbridge.com/en/news/296589986.md)
- [Mirae Asset Global Investments Co. Ltd. Grows Stake in Johnson & Johnson $JNJ](https://longbridge.com/en/news/296080198.md)
- [Johnson & Johnson Gets FDA Approval for Imaavy to Treat Warm Autoimmune Hemolytic Anemia](https://longbridge.com/en/news/296840164.md)
- [Johnson & Johnson $JNJ Position Reduced by Oppenheimer Asset Management Inc.](https://longbridge.com/en/news/296697035.md)
- [Vest Financial LLC Sells 103,567 Shares of Johnson & Johnson $JNJ](https://longbridge.com/en/news/296462162.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**